News | Magnetic Resonance Imaging (MRI) | October 07, 2016

Toshiba Showcases MR Technology at RSNA 2016

Product offerings focus on enhancing workflow, patient comfort

Toshiba America Medical Systems, MRI, RSNA 2016, Vantage Titan cS edition

October 7, 2016 — Toshiba America Medical Systems Inc. announced it will be displaying a wide array of diagnostic imaging technologies at the 2016 Radiological Society of North America (RSNA) annual meeting, Nov. 27-Dec. 2 in Chicago.

Helping healthcare providers diversify their magnetic resonance imaging (MRI) offerings and reduce their exam times, Toshiba will showcase its newest MR system at RSNA — the Vantage Titan/cS Edition, pending U.S. Food and Drug Administration (FDA) 510(k) clearance. The 1.5T system offers a suite of innovative applications to help improve patient comfort and workflow. To ensure a positive patient experience, the system features a 71 cm bore, feet-first exams and Toshiba’s Pianissimo noise-reduction technology. Helping clinicians increase workflow, Toshiba’s Vitrea Extend application permits clinicians to complete post-processing at a separate workstation, potentially allowing more patients to be scanned in the MR system. The system also offers an optional CardioLine+ application and SureVOI Cardiac technology to automatically detect anatomical landmarks for fast and accurate cardiac MR exams.

Toshiba is also introducing enhancements to its Vantage Titan 3T MR system to help clinicians improve the reproducibility and efficiency of neurological and musculoskeletal (MSK) imaging. Toshiba’s Saturn Gradient and Atlas Speeder coils have been upgraded to enable high-quality images of soft tissue and cartilage to help clinicians make diagnoses and provide rapid, effective treatment. These technology improvements help in neurological exams, which is particularly important with concussion and brain trauma cases. The system also accommodates a large range of clinical needs by pairing high-quality images with a variety of patient-friendly features, including a 71-cm patient aperture and Toshiba’s Pianissimo noise-reduction technology, among many others.

For more information: www.medical.toshiba.com

Related Content

LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
SyMRI Software Receives FDA Clearance for Use With Siemens MRI Systems
Technology | Magnetic Resonance Imaging (MRI) | June 14, 2019
SyntheticMR announced U.S. Food and Drug Administration (FDA) clearance for clinical use of its SyMRI Image and SyMRI...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Magnetic Resonance Imaging (MRI) | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...
Study Identifies MRI-Guided Radiation Therapy as Growing Market Segment
News | Image Guided Radiation Therapy (IGRT) | June 06, 2019
Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in...
Ann Arbor Startup Launches Augmented Reality MRI Simulator
Technology | Virtual and Augmented Reality | June 04, 2019
SpellBound, an Ann Arbor startup specializing in augmented reality (AR) tools for children in hospitals, has officially...

Photo courtesy of Philips Healthcare

Feature | Radiology Business | May 31, 2019 | By Arjen Radder
Change is a consistent theme in our world today, no matter where you look.
MRI Metal Artifact Reduction Poses Minimal Thermal Risk to Hip Arthroplasty Implants
News | Magnetic Resonance Imaging (MRI) | May 23, 2019
Clinical metal artifact reduction sequence (MARS) magnetic resonance imaging (MRI) protocols at 3 Tesla (3T) on hip...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...